InMed Pharmaceuticals Inc.
For the period ended May 19, 2026. Filed May 19, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 19, 2026 · Filed May 19, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.3 · Operator
Operator
Good morning and welcome to today’s conference call regarding the merger agreement between InMed Pharmaceuticals and Mentari Therapeutics. At this time, all participants are in a listen-only mode. Please be advised that the call is being recorded and will be available for replay on the InMed website. Now, I’d like to turn the call over to Colin Clancy, Vice President Investor Relations and Corporate Communications, InMed Pharmaceuticals. Please proceed.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.